Login / Signup

New regimens as first-line eradication therapy for Helicobacter pylori infection in patients allergic to penicillin: A randomized controlled trial.

Yuxin ZhangBaojun SuoXueli TianHua ZhangHaoping LuXingyu YaoCailing LiXinlu RenLi-Ya ZhouZhi-Qiang Song
Published in: Helicobacter (2023)
The efficacies of three bismuth quadruple therapies containing minocycline, cefuroxime, and full-dose metronidazole (pairwise) for first-line H. pylori eradication in penicillin-allergic patients were similarly satisfactory with relatively good safety and compliance. The study was registered in the Chinese Clinical Trials Registration (ChiCTR1900023702).
Keyphrases
  • helicobacter pylori infection
  • end stage renal disease
  • clinical trial
  • helicobacter pylori
  • ejection fraction
  • chronic kidney disease
  • peritoneal dialysis
  • patient reported outcomes
  • oxide nanoparticles